Evidence map›Paper›PMID 33375514›Full record

ArticleDiagnostics (Basel, Switzerland)2020

Diagnostic Value of CEUS Prompting Liver Biopsy: Histopathological Correlation of Hepatic Lesions with Ambiguous Imaging Characteristics.

Thomas Geyer, Dirk-André Clevert, Sonja Schwarz, Paul Reidler, Sebastian Gassenmaier, Thomas Knösel, Johannes Rübenthaler, Vincent Schwarze, Marco Armbruster

Open access · goldAbstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Microvascular Imaging of Hepatic Hemangiomas.Diagnostics (Basel, Switzerland) · 2025
    Article
  4. Article
  5. Ultrasound—New Techniques Are Extending the Applications.Deutsches Arzteblatt international · 2023
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Thomas GeyerDepartment of Radiology, Ludwig-Maximilians-University, 81377 Munich, Germany.
Dirk-André ClevertDepartment of Radiology, Ludwig-Maximilians-University, 81377 Munich, Germany.
Sonja SchwarzDepartment of Radiology, Ludwig-Maximilians-University, 81377 Munich, Germany.
Paul ReidlerDepartment of Radiology, Ludwig-Maximilians-University, 81377 Munich, Germany.
Sebastian GassenmaierDepartment of Diagnostic and Interventional Radiology, University Hospital Tuebingen, 72076 Tuebingen, Germany.ORCID 0000-0003-3701-2227
Thomas KnöselInstitute of Pathology, Ludwig-Maximilians-University, 81377 Munich, Germany.
Johannes RübenthalerDepartment of Radiology, Ludwig-Maximilians-University, 81377 Munich, Germany.ORCID 0000-0003-0832-5662
Vincent SchwarzeDepartment of Radiology, Ludwig-Maximilians-University, 81377 Munich, Germany.
Marco ArmbrusterDepartment of Radiology, Ludwig-Maximilians-University, 81377 Munich, Germany.
Ludwig-Maximilians-Universität München · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundContrast-enhanced ultrasound (CEUS) allows for dynamic analysis of vascularization patterns of unclear hepatic lesions. Our study aimed to evaluate the diagnostic performance of CEUS for further characterizing suspicious liver lesions by comparing findings from CEUS examinations with corresponding histopathology.

methodsBetween 2005 and 2016, 160 patients with unclear liver lesions underwent CEUS followed by liver biopsy. All examinations were performed by an experienced consultant radiologist (EFSUMB Level 3) and included native B-mode ultrasound, Color Doppler, and CEUS. A second-generation blood pool contrast agent was applied for CEUS.

resultsCEUS was successfully performed in all patients without occurrence of any adverse side effects. CEUS showed a sensitivity of 94.5%, a specificity of 70.6%, a true positive rate of 87.3%, and a true negative rate of 85.7% compared to histopathological results as the reference standard.

conclusionsCEUS represents a safe imaging modality with a high diagnostic accuracy in assessing both-benign and malignant-liver lesions compared to corresponding histopathological results.

Indexed as

biopsyCEUScontrast-enhanced ultrasoundhepatocellular carcinomaliver

Identifiers

PMID33375514
PMCPMC7824701
OpenAlexW3116641068

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.